Addiction therapeutics market size to increase by USD 9.86 billion between 2022 and 2027; Driven by high consumption of alcohol, tobacco, and opioid products - Technavio

NEW YORK, March 3, 2023 /PRNewswire/ -- The addiction therapeutics market size is forecast to grow by USD 9.86 billion between 2022 and 2027 at a CAGR of 7.65%. The growth of the market is driven by the high consumption of alcohol, tobacco, and opioid products. Governments and several private organizations constantly focus on increasing awareness of the ill effects caused by the consumption of alcohol, tobacco, and opioid products. However, the sales of these products are continuously increasing worldwide. This is increasing the prevalence of substance use disorders, which is driving the growth of the market. For more insights on the historic (2017 to 2021) and forecast market size (2023 to 2027) – Request a report sample

What`s New for 2023?

• Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession
• Global competitiveness and key competitor positions
• Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial

Regional Analysis

By region, the global addiction therapeutics market is segmented into North America, Europe, Asia, and the Rest of World (ROW). North America will account for 45% of market growth during the forecast period. Factors such as the rising consumption of alcohol and increased R&D efforts by vendors to develop novel therapies are driving the growth of the addiction therapeutics market in North America.

Company Profiles

The Addiction therapeutics market report includes information on the key products and recent developments of leading vendors, including:

• Amneal Pharmaceuticals Inc. - The company offers an addiction therapeutic named Butrans, which consists of a small, solid implant made from a mixture of ethylene-vinyl acetate and a drug substance that helps to stop preventing from any smoking or regular drinking habits.
• Aphios Corp. - The company offers an addiction therapeutic named NanoCanna, a nanotechnology formulation of cannabinoids for treating opioid addiction, chemotherapy-induced peripheral neuropathic pain (CIPNP), CINV, Multiple Sclerosis, and Epilepsy.
• Braeburn Inc. - The company offers addiction therapeutic named Brixadi, an extended-release weekly and monthly SC injection, indicated for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with buprenorphine.
• Emergent BioSolutions Inc. - The company offers addictions therapeutic named Narcan, a nasal spray that is used for the treatment of a known or suspected opioid overdose emergency with signs of breathing problems and severe sleepiness or not being able to respond.

Market Dynamics

The market is driven by factors such as high consumption of alcohol, tobacco, and opioid products, approval of new drugs and launch of digital therapeutics to treat addiction, and initiatives to increase awareness and combat addiction. However, the presence of generic medicines will hinder market growth.

Market Segmentation

• By distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, and others.
• By geography, the market is segmented into North America, Europe, Asia, and the Rest of World (ROW).

Get insights on the market contribution of various segments including country and region wise, historic (2017 to 2021), and forecast market size (2023 to 2027) Request a Sample

Why Buy?

• Add credibility to strategy
• Analyzes competitor's offerings
• Get a holistic view of the market

Grow your profit margin with Technavio – Buy the Report!

Related Reports:

• The smoking cessation and nicotine de-addiction market is estimated to grow at a CAGR of 12.59% between 2022 and 2027. The size of the market is forecast to increase by USD 24,529.75 million. The rising adoption of online retailing is notably driving the smoking cessation and nicotine de-addiction market growth, although factors such as health issues associated with smoking cessation products may impede the market growth.
• The cell and gene therapy market size is expected to increase by USD 9.97 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 20.15%. The increasing prevalence of chronic diseases is notably driving the cell and gene therapy market growth, although factors such as high cost and failure rate in clinical trials may impede the market growth.

Technavio's library includes over 17,000+ reports, covering more than 2,000 emerging technologies. Subscribe to our "Basic Plan" at just USD 5,000 and get lifetime access to Technavio Insights

What are the key data covered in this addiction therapeutics market report?

• CAGR of the market during the forecast period.
• Detailed information on factors that will drive the growth of the market between 2023 and 2027
• Precise estimation of the size of the addiction therapeutics market and its contribution to the parent market.
• Accurate predictions about upcoming trends and changes in consumer behavior.
• Growth of the market across North America, Europe, Asia, and the Rest of World (ROW).
• A thorough analysis of the market's competitive landscape and detailed information about vendors.
• Comprehensive analysis of factors that will challenge the growth of addiction therapeutics market vendors.

Table Of Contents:

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global addictions therapeutics market 2017 - 2021 
• Exhibit 18: Historic Market Size – Data Table on Global addictions therapeutics market 2017 - 2021 ($ billion)

• 4.2 Type Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($ billion)

• 4.3 Distribution Channel Segment Analysis 2017 - 2021 
• Exhibit 20: Historic Market Size – Distribution Channel Segment 2017 - 2021 ($ billion)

• 4.4 Geography Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ billion)

• 4.5 Country Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Distribution Channel

• 6.1 Market segments
• Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)

• 6.2 Comparison by Distribution Channel 
• Exhibit 32: Chart on Comparison by Distribution Channel
• Exhibit 33: Data Table on Comparison by Distribution Channel

• 6.3 Hospital pharmacy - Market size and forecast 2022-2027 
• Exhibit 34: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
• Exhibit 35: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
• Exhibit 36: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)

• 6.4 Retail pharmacy - Market size and forecast 2022-2027 
• Exhibit 38: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
• Exhibit 39: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
• Exhibit 40: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)

• 6.5 Others - Market size and forecast 2022-2027 
• Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)

• 6.6 Market opportunity by Distribution Channel 
• Exhibit 46: Market opportunity by Distribution Channel ($ billion)

7 Market Segmentation by Type

• 7.1 Market segments
• Exhibit 47: Chart on Type - Market share 2022-2027 (%)
• Exhibit 48: Data Table on Type - Market share 2022-2027 (%)

• 7.2 Comparison by Type
• Exhibit 49: Chart on Comparison by Type
• Exhibit 50: Data Table on Comparison by Type

• 7.3 Alcohol addiction therapeutics - Market size and forecast 2022-2027 
• Exhibit 51: Chart on Alcohol addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 52: Data Table on Alcohol addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 53: Chart on Alcohol addiction therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibit 54: Data Table on Alcohol addiction therapeutics - Year-over-year growth 2022-2027 (%)

• 7.4 Tobacco addiction therapeutics - Market size and forecast 2022-2027 
• Exhibit 55: Chart on Tobacco addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 56: Data Table on Tobacco addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 57: Chart on Tobacco addiction therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibit 58: Data Table on Tobacco addiction therapeutics - Year-over-year growth 2022-2027 (%)

• 7.5 Drug addiction therapeutics - Market size and forecast 2022-2027 
• Exhibit 59: Chart on Drug addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 60: Data Table on Drug addiction therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 61: Chart on Drug addiction therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibit 62: Data Table on Drug addiction therapeutics - Year-over-year growth 2022-2027 (%)

• 7.6 Market opportunity by Type 
• Exhibit 63: Market opportunity by Type ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 65: Chart on Market share by geography 2022-2027 (%)
• Exhibit 66: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 67: Chart on Geographic comparison
• Exhibit 68: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027 
• Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027 
• Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027 
• Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027 
• Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 Germany - Market size and forecast 2022-2027 
• Exhibit 89: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 90: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.9 Canada - Market size and forecast 2022-2027 
• Exhibit 93: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
• Exhibit 94: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
• Exhibit 95: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on Canada - Year-over-year growth 2022-2027 (%)

• 9.10 UK - Market size and forecast 2022-2027 
• Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.11 France - Market size and forecast 2022-2027 
• Exhibit 101: Chart on France - Market size and forecast 2022-2027 ($ billion)
• Exhibit 102: Data Table on France - Market size and forecast 2022-2027 ($ billion)
• Exhibit 103: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibit 104: Data Table on France - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 105: Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 106: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape
• Exhibit 107: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption
• Exhibit 108: Overview on factors of disruption

• 11.4 Industry risks
• Exhibit 109: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 110: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 111: Matrix on vendor position and classification

• 12.3 Alkermes Public Ltd. Co. 
• Exhibit 112: Alkermes Public Ltd. Co. - Overview
• Exhibit 113: Alkermes Public Ltd. Co. - Product / Service
• Exhibit 114: Alkermes Public Ltd. Co. - Key news
• Exhibit 115: Alkermes Public Ltd. Co. - Key offerings

• 12.4 Amneal Pharmaceuticals Inc. 
• Exhibit 116: Amneal Pharmaceuticals Inc. - Overview
• Exhibit 117: Amneal Pharmaceuticals Inc. - Business segments
• Exhibit 118: Amneal Pharmaceuticals Inc. - Key news
• Exhibit 119: Amneal Pharmaceuticals Inc. - Key offerings
• Exhibit 120: Amneal Pharmaceuticals Inc. - Segment focus

• 12.5 Aphios Corp.
• Exhibit 121: Aphios Corp. - Overview
• Exhibit 122: Aphios Corp. - Product / Service
• Exhibit 123: Aphios Corp. - Key offerings

• 12.6 Braeburn Inc.
• Exhibit 124: Braeburn Inc. - Overview
• Exhibit 125: Braeburn Inc. - Product / Service
• Exhibit 126: Braeburn Inc. - Key offerings

• 12.7 Emergent BioSolutions Inc. 
• Exhibit 127: Emergent BioSolutions Inc. - Overview
• Exhibit 128: Emergent BioSolutions Inc. - Product / Service
• Exhibit 129: Emergent BioSolutions Inc. - Key news
• Exhibit 130: Emergent BioSolutions Inc. - Key offerings

• 12.8 GlaxoSmithKline Plc
• Exhibit 131: GlaxoSmithKline Plc - Overview
• Exhibit 132: GlaxoSmithKline Plc - Business segments
• Exhibit 133: GlaxoSmithKline Plc - Key offerings
• Exhibit 134: GlaxoSmithKline Plc - Segment focus

• 12.9 Glenmark Pharmaceuticals Ltd. 
• Exhibit 135: Glenmark Pharmaceuticals Ltd. - Overview
• Exhibit 136: Glenmark Pharmaceuticals Ltd. - Product / Service
• Exhibit 137: Glenmark Pharmaceuticals Ltd. - Key offerings

• 12.10 Hikma Pharmaceuticals Plc 
• Exhibit 138: Hikma Pharmaceuticals Plc - Overview
• Exhibit 139: Hikma Pharmaceuticals Plc - Business segments
• Exhibit 140: Hikma Pharmaceuticals Plc - Key offerings
• Exhibit 141: Hikma Pharmaceuticals Plc - Segment focus

• 12.11 Indivior Plc
• Exhibit 142: Indivior Plc - Overview
• Exhibit 143: Indivior Plc - Product / Service
• Exhibit 144: Indivior Plc - Key offerings

• 12.12 Mallinckrodt Plc
• Exhibit 145: Mallinckrodt Plc - Overview
• Exhibit 146: Mallinckrodt Plc - Business segments
• Exhibit 147: Mallinckrodt Plc - Key news
• Exhibit 148: Mallinckrodt Plc - Key offerings
• Exhibit 149: Mallinckrodt Plc - Segment focus

• 12.13 Orexo AB
• Exhibit 150: Orexo AB - Overview
• Exhibit 151: Orexo AB - Product / Service
• Exhibit 152: Orexo AB - Key offerings

• 12.14 Otsuka Holdings Co. Ltd. 
• Exhibit 153: Otsuka Holdings Co. Ltd. - Overview
• Exhibit 154: Otsuka Holdings Co. Ltd. - Business segments
• Exhibit 155: Otsuka Holdings Co. Ltd. - Key offerings
• Exhibit 156: Otsuka Holdings Co. Ltd. - Segment focus

• 12.15 Pfizer Inc.
• Exhibit 157: Pfizer Inc. - Overview
• Exhibit 158: Pfizer Inc. - Product / Service
• Exhibit 159: Pfizer Inc. - Key news
• Exhibit 160: Pfizer Inc. - Key offerings

• 12.16 Teva Pharmaceutical Industries Ltd. 
• Exhibit 161: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 162: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 163: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 164: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 165: Teva Pharmaceutical Industries Ltd. - Segment focus

• 12.17 Titan Pharmaceuticals Inc. 
• Exhibit 166: Titan Pharmaceuticals Inc. - Overview
• Exhibit 167: Titan Pharmaceuticals Inc. - Product / Service
• Exhibit 168: Titan Pharmaceuticals Inc. - Key offerings

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 169: Inclusions checklist
• Exhibit 170: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 171: Currency conversion rates for US$

• 13.4 Research methodology
• Exhibit 172: Research methodology
• Exhibit 173: Validation techniques employed for market sizing
• Exhibit 174: Information sources

• 13.5 List of abbreviations 
• Exhibit 175: List of abbreviations

• Health: Includes veterinary drugs (excluded from the scope of the report)

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio